KR890700004A - 칼슘화합물 및 시트르산의 가용성 혼합물에 얻어진 액체 칼슘 보충제 - Google Patents

칼슘화합물 및 시트르산의 가용성 혼합물에 얻어진 액체 칼슘 보충제

Info

Publication number
KR890700004A
KR890700004A KR1019880700894A KR880700894A KR890700004A KR 890700004 A KR890700004 A KR 890700004A KR 1019880700894 A KR1019880700894 A KR 1019880700894A KR 880700894 A KR880700894 A KR 880700894A KR 890700004 A KR890700004 A KR 890700004A
Authority
KR
South Korea
Prior art keywords
calcium
citric acid
composition
compound
calcium hydroxide
Prior art date
Application number
KR1019880700894A
Other languages
English (en)
Inventor
와이.씨.백 차알스
비.왈스도르프 네일
Original Assignee
원본미기재
보오드 오브 리젠쯔 더 유니버시티 오브 텍사스 시스템
미숀 파마칼 컴패니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 보오드 오브 리젠쯔 더 유니버시티 오브 텍사스 시스템, 미숀 파마칼 컴패니 filed Critical 원본미기재
Publication of KR890700004A publication Critical patent/KR890700004A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/68—Acidifying substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

칼슘화합물 및 시트르산의 가용성 혼합물에서 얻어진 액체 칼슘 보충제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (17)

  1. 주성분으로 시트르산과, 수산화칼슘, 탄산칼슘과 산화칼슘으로 구성되는 그룹으로부터 선택된 하나 이상의 칼슘 화합물로 구성되는 조성물.
  2. 시트르산과, 수산화칼슘, 탄산칼슘과 산화칼슘으로 구성되는 그룹으로부터 선택된 하나 이상의 칼슘 화합물을 거의 무수 혼합물로 함유하는 조성물.
  3. 수산화칼슘과 시트르산이 약 0.6 내지 3.0의 수산화칼슘/시트르산 몰 비율로써 구성된 조성물.
  4. 물에 용해되어 용해성 칼슘 시트레이트를 함유하는 액체의 식이 칼슘 보충제를 형성하는 조성물에 있어서, 그 조성물질이 거의 무수상태이며 주로 시트르산과, 수산화칼슘, 탄산칼슘과 산화칼슘으로 구성되는 그룹으로부터 선택되는 칼슘 화합물로 이루어지고, 칼슘 화합물과 시트르산이 약 0.6 내지 3.0의 칼슘 화합물/시트르산 몰 비율로 존재함을 특징으로 하는 조성물.
  5. 제1항, 제2항, 제3항 또는 제4항에 있어서, 하나 이상의 향미제, 윤활제, 감미제 또는 착색제를 함유하는 조성물.
  6. 제1항, 제2항, 제3항 또는 제4항에 있어서, 칼슘화합물/시트르산 또는 수산화칼슘/시트르산 몰 비율이 약 1.25인 조성물.
  7. 제1항, 제2항, 제3항 또는 제4항에 있어서, 약 1.5이하의 포스포러스/시트레이트 중량비율을 갖는 조성물.
  8. 수산화 칼슘과 시트르산을 수산화칼슘/시트르산 몰비율을 약 0.6 내지 약 3.0으로 혼합함을 특징으로 하여 수용성 용매중에서 용해되어 칼슘 시트레이트가 주성분인 음료 액체를 이루는 혼합물을 제조하는 방법.
  9. 칼슘 시트레이트와 시트르산이 주성분인 음료 액체의 제조방법에 있어서, 수산화칼슘과 시트르산을 수산화칼슘/시트르산의 비율이 약 0.60 내지 약 3.0이 되도록 함유하는 혼합물을 제조하고, 수용성 용매에 그 혼합물을 용해시키는 것을 특징으로 하는 방법.
  10. 칼슘의 신장 결석이 촉진되거나 증가되는 위험성이 없이 칼슘의 식이요법적 보충에 적합한 음료 액체에 있어서, 수산화칼슘, 산화칼슘과 탄산칼슘으로 구성되는 그룹으로부터 선택된 칼슘 혼합물과 시트르산과 물이 주성분인 음료액체.
  11. 제10항에 있어서, 약 2 내지 약 7의 pH를 갖는 음료 액체.
  12. 제10항에 있어서, 약 3 내지 약 5의 pH를 갖는 음료 액체.
  13. 제10항에 있어서, 칼슘 화합물과 시트르산이 칼슘화합물/시트르산의 몰 비율이 약 0.6 내지 약 3.0이 되도록 존재하는 음료 액체.
  14. 제10항에 있어서, 약 500mg/l 내지 약 2000mg/l의 농도로 칼슘을 함유하는 음료 액체.
  15. 제10항에 있어서, 칼슘 화합물이 수산화칼슘인 음료 액체.
  16. 제10항에 있어서, 칼슘 화합물과 시트르산이 칼슘화합물/시트르산 몰비율이 약 0.6 내지 1.5가 되도록 존재하는 음료 액체.
  17. 제10항에 있어서, 약 1.5이하의 포스포러스/시트레이트의 중량비율을 갖는 음료 액체.
    ※ 참고사항：최초출원 내용에 의하여 공개하는 것임.
KR1019880700894A 1986-11-26 1987-11-24 칼슘화합물 및 시트르산의 가용성 혼합물에 얻어진 액체 칼슘 보충제 KR890700004A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/935,666 US4851221A (en) 1985-02-19 1986-11-26 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
US935666 1986-11-26
PCT/US1987/003066 WO1988003762A1 (en) 1986-11-26 1987-11-24 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid

Publications (1)

Publication Number Publication Date
KR890700004A true KR890700004A (ko) 1989-03-02

Family

ID=25467492

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700894A KR890700004A (ko) 1986-11-26 1987-11-24 칼슘화합물 및 시트르산의 가용성 혼합물에 얻어진 액체 칼슘 보충제

Country Status (11)

Country Link
US (1) US4851221A (ko)
EP (1) EP0329708B1 (ko)
JP (1) JP2614909B2 (ko)
KR (1) KR890700004A (ko)
AT (1) ATE84400T1 (ko)
AU (1) AU605819B2 (ko)
CA (1) CA1297034C (ko)
DE (1) DE3783610T2 (ko)
DK (1) DK169231B1 (ko)
NO (1) NO172273C (ko)
WO (1) WO1988003762A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100380983B1 (ko) * 2000-11-16 2003-05-01 주식회사 백광소재 비표면적이 큰 고반응성 수산화칼슘의 제조방법

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496569A (en) * 1988-10-21 1996-03-05 The Regents Of The University Of California Simultaneous treatment of osteoporosis and hypertension with potassium bicarbonate
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
US5228445A (en) * 1990-06-18 1993-07-20 Board Of Regents, The University Of Texas System Demonstration by in vivo measurement of reflection ultrasound analysis of improved bone quality following slow-release fluoride treatment in osteoporosis patients
US5149552A (en) * 1991-05-23 1992-09-22 Kraft General Foods, Inc. Calcium citrate anticaking agent
CA2146633C (en) * 1992-10-21 1998-09-01 Mark Benson Andon Concentrated bioavailable calcium source
CA2146632C (en) * 1992-10-21 1999-02-23 Alice Lyles Burkes Sweetener containing a concentrated bioavailable calcium source
ES2089858T3 (es) * 1992-10-21 1996-10-01 Procter & Gamble Concentrados de premezcla para bebidas suplementados con calcio y estables en almacenamiento.
US5376553A (en) * 1993-06-18 1994-12-27 University Of Florida Clinical marker and therapeutic agent in kidney stone disease and methods of use
US5474793A (en) * 1994-05-10 1995-12-12 Meyer; Larry E. Process for preparing calcium-supplemented not-from-concentrate fruit juice beverages
US5500232A (en) * 1994-10-06 1996-03-19 Bristol-Myers Squibb Company Calcium fortified beverages
GB9603518D0 (en) * 1996-02-20 1996-04-17 Smithkline Beecham Plc Novel process
US6818228B1 (en) 1996-06-21 2004-11-16 Mission Pharmacal Company Dietary supplements containing ultradense calcium citrate and carbonyl iron
GB9717598D0 (en) * 1997-08-19 1997-10-22 Smithkline Beecham Plc Novel composition and use
GB9819530D0 (en) 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
US6811800B2 (en) * 1998-09-29 2004-11-02 The Procter & Gamble Co. Calcium fortified beverages
GB2343100A (en) * 1998-10-29 2000-05-03 James Warren Patrick Moisture and temperature stable effervescent composition
US6558711B1 (en) * 1998-12-16 2003-05-06 The Trustees Of Dartmouth College Composition and method for reducing the risk of carcinogenesis
US6251439B1 (en) * 1998-12-16 2001-06-26 Trustee Of The Dartmouth College Composition and method for reducing the risk of carcinogenesis
US6235322B1 (en) 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
US6287607B2 (en) 1999-07-19 2001-09-11 Mission Pharmacal Company Potassium calcium citrate compositions and methods therefor
US6051567A (en) 1999-08-02 2000-04-18 Abbott Laboratories Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
US6274169B1 (en) 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
US6669979B1 (en) 2000-01-11 2003-12-30 Jifu Zhao Method for promoting extraction of beneficial compounds into beverages naturally containing same, and for extending the duration of freshness of coffee
US7713566B2 (en) * 1999-12-21 2010-05-11 Zapp Loretta M Method for enhancing post-processing content of beneficial compounds in beverages
US6723368B1 (en) * 1999-12-21 2004-04-20 Loretta M. Zapp Method for enhancing post-processing content of beneficial compounds in beverages naturally containing same
US6660322B2 (en) 1999-12-21 2003-12-09 Loretta Zapp Method for enhancing post-processing content of beneficial compounds in foodstuffs made with cocoa beans
EP1242067B1 (en) * 1999-12-22 2006-07-26 Wisconsin Alumni Research Foundation Calcium formate as a dietary supplement
US6160016A (en) 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
US6803064B1 (en) 2000-06-14 2004-10-12 Pepsico, Inc. Calcium fortified beverage compositions and process for preparing the same
AU2002211770A1 (en) 2000-10-16 2002-04-29 Pepsico, Inc. Calcium-supplemented beverages and method of making same
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
KR20010098992A (ko) * 2001-07-30 2001-11-09 박성식 석회석 또는 패각류를 이용한 수소구연산칼슘과구연산칼슘 제조 방법
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
JP5204359B2 (ja) * 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
US20020128320A1 (en) * 2001-12-10 2002-09-12 Uniservices Ltd. Method of administering calcium citrate
US20030211204A1 (en) * 2002-05-10 2003-11-13 Fields Christine C. Method of preparing beverages and beverage concentrates nutritionally supplemented with minerals
US6833146B2 (en) * 2002-07-08 2004-12-21 Unilab Pharmatech, Ltd. Powered beverage mix with rapidly dissolving calcium
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
US7138151B2 (en) * 2002-11-22 2006-11-21 Unilab Pharmatech, Ltd. Calcium-fortified acidic beverages
US20040170724A1 (en) * 2003-02-28 2004-09-02 Kraft Foods Holdings, Inc. Mineral complexes of lactobionic acid and method of using for mineral fortification of food products
US7422761B2 (en) * 2003-12-03 2008-09-09 Tropicana Products, Inc. In-line process for preparing calcium-supplemented juice beverages
US7927640B2 (en) * 2004-02-02 2011-04-19 Delavau Llc Calcium fortification of bread dough
US7169417B2 (en) * 2004-02-02 2007-01-30 Delavau Llc Calcium fortification of bread dough
US7166313B2 (en) * 2004-02-02 2007-01-23 Delavau L.L.C. Calcium fortification of bread dough
US7595075B2 (en) * 2004-02-02 2009-09-29 Delavau Llc Calcium fortification of bread dough
US7267832B2 (en) * 2004-02-18 2007-09-11 Kraft Foods Holdings, Inc. Amorphous water-soluble calcium citrate salts and method of making and using same
US7323201B2 (en) * 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
AU2005263337B2 (en) 2004-07-23 2009-01-22 Ice Medico Ehf Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva
WO2007035760A1 (en) * 2005-09-20 2007-03-29 Board Of Regents, The University Of Texas System Enhanced solubility of preformed calcium citrate by adding citric acid
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US9750715B2 (en) 2006-01-30 2017-09-05 Panion & Biotech Inc. Method of reversing, preventing, delaying or stabilizing soft tissue calcification
US7985429B2 (en) 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
IL174477A (en) * 2006-03-22 2011-03-31 Gadot Biochemical Ind Ltd Calcium enrichment compositions and methods of production thereof
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
WO2009026342A1 (en) * 2007-08-23 2009-02-26 Novartis Ag Dietary supplement fiber composition with calcium and chelating agent
EP2194977A1 (en) 2007-08-31 2010-06-16 C.B. Fleet Company Incorporated Method of preventing nephrocalcinosis
JP5371278B2 (ja) * 2008-04-03 2013-12-18 エイワイファーマ株式会社 透析用剤およびその製造方法
JP2010200706A (ja) * 2009-03-05 2010-09-16 Shiraishi Kogyo Kaisha Ltd カルシウム強化炭酸飲料の製造方法
CN102151285B (zh) * 2010-02-11 2013-01-16 北京新世纪达康生物科技开发有限责任公司 中性补钙制剂
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
CN102633627A (zh) * 2012-04-01 2012-08-15 江南大学 固相合成柠檬酸钙的方法
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
JP5689549B1 (ja) * 2014-02-27 2015-03-25 ポッカサッポロフード＆ビバレッジ株式会社 酸性飲料
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
IT201700099690A1 (it) * 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio
PT3823470T (pt) * 2018-07-19 2022-09-19 Csm Bakery Solutions Europe Holding B V Concentrado de cálcio
CN114711432A (zh) * 2022-04-27 2022-07-08 云南莱德福科技有限公司 水溶钙及其制备方法和钙剂及水溶钙的应用
WO2024108133A1 (en) * 2022-11-18 2024-05-23 5-Hour International Corporation Private Limited Hydration management product

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH193065A (de) * 1936-11-28 1937-09-30 Paul Dr Med Ourinowsky Verfahren zur Herstellung eines die Kalkbindung im menschlichen Körper anregenden Tonikums.
DE761525C (de) * 1942-01-10 1951-05-21 Boehringer Sohn Ingelheim Verfahren zur Herstellung von primaerem Calciumcitrat
GB597936A (en) * 1943-11-08 1948-02-06 Miles Lab Improvements in or relating to the manufacture of mono-calcium citrate dihydrate
US2953459A (en) * 1957-05-10 1960-09-20 Henry Brout Effervescive concentrate
US3105792A (en) * 1960-11-29 1963-10-01 Warner Lambert Pharmaceutical Stable effervescent compositions and method of preparing same
FR4384M (ko) * 1965-06-08 1966-08-29
GB1300969A (en) * 1969-03-26 1972-12-29 Organon Nv Novel modified acid crystals and a process for their preparation
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
US4107346A (en) * 1976-09-02 1978-08-15 Kravitz Hilard L Dietary salt compositions
US4185093A (en) * 1977-07-14 1980-01-22 Carnes Allen R Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4214996A (en) * 1978-12-19 1980-07-29 R.G.B. Laboratories, Inc. Mineral enrichment composition and method of preparing same
DE3014503A1 (de) * 1980-04-16 1981-10-22 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Kontinuierliches verfahren zur gewinnung von tricalciumcitrat aus citronensaeure enthaltenden loesungen
EP0052677B1 (en) * 1980-11-21 1985-01-09 Monsanto Company Concentrates for the preparation of carbonated beverages
GR77674B (ko) * 1981-09-14 1984-09-25 Philip Morris Inc
CA1209040A (fr) * 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
US4551342A (en) * 1983-02-01 1985-11-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
US4814177A (en) * 1986-03-18 1989-03-21 Board Of Regents, University Of Texas System Ultradense and more soluble and bioavailable preparations of calcium citrate
JP3085499B2 (ja) * 1993-10-05 2000-09-11 株式会社日立製作所 圧延機制御方法および装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100380983B1 (ko) * 2000-11-16 2003-05-01 주식회사 백광소재 비표면적이 큰 고반응성 수산화칼슘의 제조방법

Also Published As

Publication number Publication date
EP0329708B1 (en) 1993-01-13
JPH02501619A (ja) 1990-06-07
NO172273C (no) 1993-06-30
AU8334787A (en) 1988-06-16
DK417688A (da) 1988-09-26
CA1297034C (en) 1992-03-10
WO1988003762A1 (en) 1988-06-02
US4851221A (en) 1989-07-25
EP0329708A1 (en) 1989-08-30
JP2614909B2 (ja) 1997-05-28
NO883308D0 (no) 1988-07-26
NO883308L (no) 1988-09-26
DK169231B1 (da) 1994-09-19
AU605819B2 (en) 1991-01-24
DK417688D0 (da) 1988-07-26
ATE84400T1 (de) 1993-01-15
DE3783610T2 (de) 1993-08-12
NO172273B (no) 1993-03-22
DE3783610D1 (de) 1993-02-25

Similar Documents

Publication Publication Date Title
KR890700004A (ko) 칼슘화합물 및 시트르산의 가용성 혼합물에 얻어진 액체 칼슘 보충제
ES8502873A1 (es) Metodo de preparacion de soluciones para dialisis.
JPS5697248A (en) Conjugated compound of calcium citrate and calcium malate and its preparation
PT1382263E (pt) Utilização de cálcio em composições orais acídicas, para a redução da erosão dentária causada por ácido
EP0115216A2 (en) Health promotion composition
KR870008580A (ko) 항치석 치약
KR930011837A (ko) 시트르산칼슘-식물유 조성물
KR920007571A (ko) 영양학적 조성물 및 이의 제조방법
HUT35284A (en) Preparatives consisting of bipolimers and process for their production
AU4017995A (en) Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
KR870009707A (ko) 플루오르화 치마제용 디칼슘포스페이트 디하이드레이트 조성물 및 그 제조 방법과 이를 함유하는 치약
KR970706741A (ko) 산호 모래 또는 산호 화석을 이용한 미네랄 함유물(mineral preparation containing coral sand or corallite)
RU2165727C1 (ru) Способ приготовления минеральной воды
US2589900A (en) Solution of nutritive salts and process of making the same
KR960006787A (ko) 해초(海草) 저염(低鹽) 맛소금의 제조방법
CN1154358A (zh) 氨基酸钙的制备方法及其应用
JPS5511029A (en) Production of moisture containing coagulated alginate
CA2252670A1 (en) Low ph acidic compositions
JPS56131342A (en) Preparation of readily meltable process cheese
JPS55138371A (en) Preparation of flavor formulation
EP1810684A3 (en) Anticancer agent
RU2003129267A (ru) Композиции, содержащие креатин и креатинин
RU1807856C (ru) Способ приготовлени щелочной лечебно-столовой воды
CA2113486C (en) Palatable low salt substitutes
JPH0881367A (ja) 高濃度カルシウム含有液剤

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid